US EditionTrump Administration Gives Pro-Lifers a Few Wins While Protecting the Holy Grail: Abortion Pills
4 Articles
4 Articles
Trump administration gives pro-lifers a few wins while protecting the holy grail: abortion pills
National Institutes of Health changes policies on human fetal tissue research, embryonic stem cell lines to coincide with March for Life, but wealthy pro-life group joins with street activists to denounce protection for mifepristone.
Historic Pro-life Wins Under President Trump and the Work Left Ahead
Last Friday, tens of thousands of Americans of every age, creed, and kind marched down Constitution Avenue towards the nation’s capital with one, united purpose: to be a voice for the voiceless in a broken world that considers the unborn disposable. Vice President JD Vance headlined the March for Life rally with bold remarks: “The […]
Trump Ending Funding for Research With Aborted Baby Parts is a Huge Pro-Life Victory
The day before the 2026 March for Life, the Trump administration announced a pro-life policy change that advocates have pursued for more than two decades. “Effective the date of this Notice,” announced the National Institutes of Health (NIH), “NIH funds will not be permitted for research using HFT [human fetal tissue] from elective abortions.” In response to the announcement, Science Alliance for Life and Technology President Dr. David Prentice …
The Government of Donald Trump, in the United States, decided on Friday 22, the end of federal funding for studies using soft fetal tissue after abortions. The National Institute of Health (NIH) justified the measure as part of the commitment to support innovative technologies that reflect both current and current U.S. values, according to Jay Bhattacharya, director of the organ. + Read more World News in the West The position was praised by gro…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
